← Back to Search

Polyphenols

Raspberry Supplement for Metabolic Syndrome

N/A
Waitlist Available
Led By Marie-Claude Vohl
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least one of the following: BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights

Study Summary

This trial will study the effects of raspberries on the gut microbiota and intestinal integrity to see if they can help prevent obesity-linked metabolic syndrome.

Who is the study for?
This trial is for men and premenopausal women in good health with a BMI between 25-40 or waist size over 80 cm for women and 94 cm for men, plus high triglycerides or fasting insulin. Participants must be Caucasian without significant weight change recently, no raspberry allergies/intolerances, low alcohol consumption, not on certain diets or medications that could affect the study.Check my eligibility
What is being tested?
The trial is testing if raspberry supplements can help improve gut bacteria and prevent obesity-related metabolic syndrome. It involves studying changes in participants' gut microbiota, gene expression related to metabolism (transcriptomics), and small molecules produced by cells (metabolomics) after taking the supplement.See study design
What are the potential side effects?
Potential side effects are not detailed but may include typical reactions to dietary supplements such as digestive discomfort. Since raspberries are generally considered safe to eat, severe side effects are unlikely; however individual tolerances vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is between 25 and 40, or my waist size meets the required measurements.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in plasma insulin/glucose of overweight/obese men and women taking frozen raspberries daily or following their usual diet (control group).
Changes in plasma lipides/lipoproteins of overweight/obese men and women taking frozen raspberries daily or following their usual diet (control group).
Secondary outcome measures
Changes in gene expression in overweight/obese men and women taking frozen raspberries daily or following their usual diet (control group).
Inflammation
Changes in intestinal integrity (plasma lipopolysaccharide (LPS) and LPS binding protein (LBP) will be measured) of overweight/obese men and women taking frozen raspberries daily or following their usual diet (control group).
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Raspberry supplementationExperimental Treatment1 Intervention
Dietary Supplement: 280g of frozen raspberries, taken daily for 8 weeks. Subjects will consume frozen raspberry to test if there is a significant difference on the impact on gut microbiota composition and metabolic syndrome parameters between this treatment and control group (without raspberry).
Group II: ControlActive Control1 Intervention
Control: follow their usual diet (control group). Subjects will follow their usual diet and not consume raspberry to test if there is a significant difference on the impact on gut microbiota composition and metabolic syndrome parameters between this treatment and the experimental group (with raspberry).

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,213 Total Patients Enrolled
Marie-Claude VohlPrincipal InvestigatorLaval University
3 Previous Clinical Trials
123 Total Patients Enrolled

Media Library

Raspberry supplement (Polyphenols) Clinical Trial Eligibility Overview. Trial Name: NCT03620617 — N/A
Gut Microbiome Research Study Groups: Control, Experimental: Raspberry supplementation
Gut Microbiome Clinical Trial 2023: Raspberry supplement Highlights & Side Effects. Trial Name: NCT03620617 — N/A
Raspberry supplement (Polyphenols) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03620617 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria makes someone a suitable participant for this investigation?

"To participate in the trial, applicants must have metabolic syndrome and be aged between 18 and 60. A total of 59 people are required to take part."

Answered by AI

Is enrollment for this trial still available to prospective participants?

"As of September 6th 2022, this clinical trial is no longer recruiting patients. First posted on the 8th of January 2018, it has since been closed to new participants. Nevertheless, there are still 1481 other trials seeking enrolment at present."

Answered by AI

Is this experiment open to those aged 60 and over?

"This trial is seeking the participation of adult individuals aged 18 or above, but below 60 years old."

Answered by AI
Recent research and studies
~8 spots leftby Apr 2025